sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'dzd9008']
 sunvozertinib (dzd9008) in egfr exon20ins from the ph2 wu-kong6 orr by bicr 60.8% orr in baseline brain 48.5% mdor nr safety consistent w/ previous tkis 30 different exon20ins subtypes were enrolled ( the need of ngs to identify all of these pts) #asco23 
MD PhD, lung oncologist & researcher @IEOufficiale; @myESMO Communication Committee Chair; #LungCancer Molecular target-believer #LCSM